1. CPMP, Committee for proprietary Medicinal Products, Note on guidance on the Investigation of bioavailability and bioequivalence, The European Agency for the Evaluation of Medicinal products, 1998.
2. FDA, Food and Drug Administration, Guidance for Industry, Dissolution testing of immediate release solid dosage oral forms, US Department of Health and Human Services, Centre for drug Evaluation and Research, Washington, 1997.
3. United States Pharmacopoeia (USPXXII) (National Formulary), pp. 1578–1579.
4. British Pharmacopoeia, Her Majesty's Stationary Office, London, 1993, pp. 547–586.
5. Real Farmacopea Española, Ministerio de Sanidad y Consumo, Madrid, 1997, pp. 1601–1720.